Why the Trump CBD reimbursement promise isn’t helping hemp operators – or patients
The looming federal hemp ban is discouraging healthcare organizations from participating in a Trump administration effort to offer reimbursements for hemp-derived CBD products. And hemp companies aren't reporting revenue. Why the Trump CBD reimbursement promise isn’t helping hemp
The looming federal hemp ban is discouraging healthcare organizations from participating in a Trump administration effort to offer reimbursements for hemp-derived CBD products. And hemp companies aren't reporting revenue.
Why the Trump CBD reimbursement promise isn’t helping hemp This story matters for Cannabis & Hemp readers tracking hemp. Reported by mjbizdaily.com. Read the full original at the source link below.
Originally reported by mjbizdaily.com. HempNews.com curates and briefs the cannabis & hemp stories that matter. Our editorial policy →
Get the daily hemp signal